Relation of Obesity to Survival After In-Hospital Cardiac Arrest

Tanush Gupta1, Dhaval Kolte2, Divyanshu Mohananey3

  • 1Division of Cardiology, Department of Medicine, New York Medical College, Valhalla, New York.

Insights

The obesity paradox suggests obese patients with in-hospital cardiac arrest (IHCA) have better survival rates. This study found obese individuals had higher risk-adjusted survival to hospital discharge after IHCA.

Area of Science:

  • Cardiology
  • Public Health
  • Obesity Medicine

Background:

  • Obesity is paradoxically linked to better outcomes in cardiovascular diseases.
  • The impact of obesity on survival following in-hospital cardiac arrest (IHCA) remains underexplored.

Purpose of the Study:

  • To investigate the association between obesity and survival rates in patients experiencing IHCA.
  • To determine if the 'obesity paradox' extends to IHCA outcomes.

Main Methods:

  • Utilized the 2003-2011 Nationwide Inpatient Sample databases.
  • Identified adult patients (≥18 years) who underwent cardiopulmonary resuscitation for IHCA.
  • Employed multivariate regression models to compare survival to hospital discharge between obese and nonobese patients, adjusting for risk factors.

Main Results:

  • A total of 836,289 IHCA patients were analyzed, with 8.0% identified as obese.
  • Obese patients were younger and more likely female, yet presented with higher rates of cardiovascular comorbidities.
  • After risk adjustment, obese patients demonstrated significantly improved survival to hospital discharge (adjusted odds ratio 1.15).

Conclusions:

  • This large-scale retrospective analysis indicates that obesity is associated with increased survival odds following IHCA.
  • The findings support the existence of an 'obesity paradox' in the context of in-hospital cardiac arrest.
  • Obesity may confer a survival advantage in patients experiencing IHCA, warranting further investigation.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
357
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
332
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
970
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.9K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
269